Change Location
Set Price Drop Alert for:
TASIMELTEON (Generic for HETLIOZ)
- QTY 30
- 20 MG
- Capsule
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
TASIMELTEON (Generic for HETLIOZ)
- QTY 30
- 20 MG
- Capsule
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
TASIMELTEON (Generic for HETLIOZ) Lifestyle Interactions
-
Tasimelteon 20mg, Oral capsule
• Interaction: Cannabis• Severity: Major• Notes for Consumers: Discuss cannabis use with your care team. The effects of your medication may be altered if used with cannabis. Call emergency services right away if you experience slow or shallow breathing, shortness of breath, feeling faint, dizziness, confusion, or trouble staying awake.• Notes for Professionals: Advise patients to avoid cannabis use while taking CNS depressants due to the risk for additive CNS depression and potential for other cognitive adverse reactions. -
Tasimelteon 20mg, Oral capsule
• Interaction: Alcohol• Severity: Major• Notes for Consumers: Do not drink alcohol while taking this medication. Drinking alcohol may alter the effects of your medication. Serious side effects may occur. Contact your care team if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid alcohol consumption while taking tasimelteon. A single dose study indicated a trend towards additive effects of tasimelteon and alcohol on some psychomotor tests. -
Tasimelteon 20mg, Oral capsule
• Interaction: Tobacco• Severity: Major• Notes for Consumers: Do not smoke or use tobacco products while taking this medication. When used together, your medication may not work as well for you.• Notes for Professionals: Advise patients to avoid smoking tobacco while taking tasimelteon. Due to partial metabolism of tasimelteon by CYP1A2, drug exposure is decreased by about 40% in smokers compared to non-smokers. Patients should be advised of the potential for reduced efficacy due to tobacco use.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.